| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |